An oral vaccine based on stable peptide-chitosan conjugate targeting DEC-205 for cancer immunotherapy
{{output}}
The development of oral vaccines faces significant challenges mainly due to the harsh gastrointestinal environment and low antigen-uptake efficiency. The gut-associated lymphoid tissue (GALT), particularly Peyer's patches (PPs), contains abundant immune cells... ...
